P

Inventor

DOHIL RANJAN

US34 patents
⚠️ This page may combine multiple inventors who share the name “DOHIL RANJAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV CALIFORNIA

27 patents
US8026284B2Sep 27, 2011

Enterically coated cystamine, cysteamine and derivatives thereof

UNIV CALIFORNIA34 citations96
US9814689B2Nov 14, 2017

Enterically coated cysteamine, cystamine and derivatives thereof

UNIV CALIFORNIA7 citations92
US9795578B2Oct 24, 2017

Enterically coated cysteamine, cystamine and derivatives thereof

UNIV CALIFORNIA7 citations92
US9511039B2Dec 6, 2016

Enterically coated cysteamine, cystamine and derivatives thereof

UNIV CALIFORNIA14 citations92
US9198882B2Dec 1, 2015

Enterically coated cysteamine, cystamine and derivatives thereof

UNIV CALIFORNIA12 citations92
US10272037B2Apr 30, 2019

Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

UNIV CALIFORNIA13 citations91
US9782347B2Oct 10, 2017

Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

UNIV CALIFORNIA14 citations91
US10485774B2Nov 26, 2019

Enterically coated cysteamine, cystamine and derivatives thereof

UNIV CALIFORNIA2 citations84
US9925157B2Mar 27, 2018

Enterically coated cysteamine, cystamine and derivatives thereof

UNIV CALIFORNIA2 citations84
US9925156B2Mar 27, 2018

Enterically coated cysteamine, cystamine and derivatives thereof

UNIV CALIFORNIA2 citations84
US9925158B2Mar 27, 2018

Enterically coated cysteamine, cystamine and derivatives thereof

UNIV CALIFORNIA2 citations84
US9750708B2Sep 5, 2017

Enterically coated cysteamine, cystamine and derivatives thereof

UNIV CALIFORNIA5 citations84
US9192590B2Nov 24, 2015

Enterically coated cysteamine, cystamine and derivatives thereof

UNIV CALIFORNIA6 citations84
US7994226B2Aug 9, 2011

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

UNIV CALIFORNIA7 citations84
US9119863B2Sep 1, 2015

Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

UNIV CALIFORNIA8 citations82
US8975243B2Mar 10, 2015

Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

UNIV CALIFORNIA10 citations82
US11311507B2Apr 26, 2022

Enterically coated cysteamine, cystamine and derivatives thereof

UNIV CALIFORNIA0 citations73
US11413296B2Aug 16, 2022

Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

UNIV CALIFORNIA1 citations71
US10537528B2Jan 21, 2020

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds

UNIV CALIFORNIA2 citations69
US9511038B2Dec 6, 2016

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

UNIV CALIFORNIA1 citations63
US11576871B2Feb 14, 2023

Formulations of cysteamine and cystamine

UNIV CALIFORNIA0 citations62
US11197822B2Dec 14, 2021

Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

UNIV CALIFORNIA0 citations61
US12391643B2Aug 19, 2025

Substituted amino-thiol and amino-disulfide compounds, and uses thereof

UNIV CALIFORNIA0 citations60
US12268777B2Apr 8, 2025

Compositions and methods for treating eosinophilic disorders

UNIV CALIFORNIA0 citations56
US11547664B2Jan 10, 2023

Compositions and methods for treating eosinophilic disorders

UNIV CALIFORNIA0 citations56
US12576051B2Mar 17, 2026

Methods and composition for treating respiratory obstructive diseases

UNIV CALIFORNIA0 citations53
US10307386B2Jun 4, 2019

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

UNIV CALIFORNIA0 citations52

DOHIL RANJAN

6 patents

HORIZON ORPHAN LLC

1 patent